Multicenter study to transplant hepatitis C-infected kidneys (MYTHIC): An open-label study of combined glecaprevir and pibrentasvir to treat recipients of transplanted kidneys from deceased donors with hepatitis C virus infection
Journal of the American Society of Nephrology | Aug 30, 2020
Most read this week